Artificial Insemination Market 2018 Striking Double Digit 10.9% CAGR Growth Rate by 2023

Global Artificial Insemination Market is expected to reach USD 1.95 billion in 2023 from USD 1.35 billion in 2016 with a CAGR of approximately 10.9% during the forecast period 2017-2023. Artificial Insemination is a treatment for infertility. It is a medical process involving introduction of semen into the female reproductive tract. It is recommended to the couples experiencing unexplained infertility or problem with intercourse. Artificial insemination has grown in popularity as infertility becomes more prevalent and as more women opt to become single mothers. The procedures for artificial insemination are legal in most of the developed countries but there are no such rules and regulations governing it. Changing lifestyle, poor reproductive health of women, psychological stress, addiction, lifestyle changes and increase in age of women at the time of first pregnancy act as drives for the growth of this market.

Globally, artificial insemination market consists of four regions Americas, Europe, Asia-Pacific and Middle East and Africa.  North America is the largest market. Presence of large number of infertility centers, technological advancement in infertility treatment and increase in reproductive disorders among women boost the growth of this market in North America. Europe is the second largest market. Asia Pacific shows fastest growth in this market. The market shows steady growth in Middle East and Africa.

Key Players:

Labotect GmbH (Germany), Hamilton Throne Ltd. (U.S.), Microtech IVF S.R.O. (Czech Republic),  Rinovum Women's Health LLC (US),  Zander scientific Inc. (U.S.),INVO Bioscience (U.S.), Nikon Instruments Inc. (U.S.), MedGyn products Inc. (U.S.),Conceivex Inc. (US), Biogenics Inc. (U.S.), LifeGlobal Group LLC (U.S.), TenderNeeds Fertility (US)  and Surelife Pte Ltd. (Singapore).

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1218 .

Innovation is the organic strategy to gain the market. Many companies are operating in the market, however, the major companies dominated the major share in the market due to well-developed brand identity. Now-a-days, there is a significant increase in the number of the company offering artificial Insemination.  Thus companies are adopting the new strategies to minimize the competition and increase the market. Some major companies are focusing on development of new and advanced products to gain the market share. Whereas, some are has used the technique of acquisition and collaboration to gain the market.

Latest Industry Updates

Being a competitive market, a number of different manufacturer are focusing on the product launch, and acquisition for the market development. Some of the latest development in the market are-

Labotect GmbH is a major player in artificial insemination market. The company develops products for use in assisted reproduction, medical science laboratories and medical surgery. Incubation technique is one of the key areas of the company helping it to maintain competitive advantage. Its products include embryo transfer catheters and puncture needle are the products for artificial insemination.

Hamilton Throne Ltd. Is a leading provider for computer aided sperm analysis and advanced laser system. IVOS, CEROS, human motility II are sperm analysis products. In September 2016, the company acquired Embryotech Laboratories, a company providing testing assays and quality control serviees

Global Artificial Insemination Market – Overview:

Intrauterine insemination is most common type of artificial dissemination. Artificial insemination helps to overcome problems in conceiving. This is one of the major advantages of artificial insemination. Increase in success rates of treatment of infertility favor the growth of artificial insemination. In the United States, 12 percent of women aged 15 to 44 years are unable to conceive after one year of unprotected sex. According to the Centers for Disease Control and Prevention (CDC) suggest that a woman should consider seeing an infertility doctor to discuss treatment if she has not conceived within one year of trying to, has irregular periods, is over the age of 35, or has experienced two or more spontaneous miscarriages. Rising social acceptance has also played an important role in the growth of the global artificial insemination market.  Increase in awareness about infertility and reproductive health and decrease in cost of treatment of fertility treatment drive the market for artificial insemination. Additionally, increasing healthcare expenditure and rapidly growing economies have fuelled the growth of the market. These factors are restraining the adoption of artificial insemination kits which could limit the growth of the global artificial insemination market.

Regional Analysis:

Depending on geographic region, artificial insemination market is segmented into four key regions: Americas, Europe, Asia-Pacific and Middle East and Africa. North America is the largest market. The cost of artificial insemination in America in between USD 300 to USD 500 per attempt. According to American Society of Reproductive Health, the typical success rate is 10 to 20 percent.  Continuous increasing in number of fertility clinics in the U.S and Canada, increase in drug addiction and smoking among women, unprotected sexual intercourse and rising trend of planned pregnancy favor the growth of this market in America. The European market is also growing continuously. Deterioration of reproductive health among women, increased age of women at the time of pregnancy, rising income of families and demand of technological advancement in artificial insemination drive this market in Europe. Asia-Pacific market is expected to show fastest growth in the Artificial insemination market during the forecasted period. Rise in number of miscarriage, lack of awareness about reproductive health, increase in psychological and physical stress favor the growth of this market in Asia-Pacific. Government of India has number of programs for women in rural areas. In India, Janani Suraksha Yogana under National Health Mission was a great success initiating women to carry out institution delivery which provided cash assistance to pregnant women after delivery. Middle East and Africa show steady growth in this market.

Inquire more @ https://www.marketresearchfuture.com/enquiry/1218 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.